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SMPH Summary measure of population health
YLD Years lived with disability
YLL Years of life lost
15.1  Preface
Burden and risk assessment play an increasingly important and accepted role in 
defining control policies for foodborne parasites (FBPs). Burden assessment is a 
top-down approach, starting from available epidemiological data, while risk assess-
ment is a bottom-up or predictive approach, starting from exposure and dose- 
response data (Newsome et  al. 2009; Stella et  al. 2013). Both methods however 
share a common goal of generating estimates of the health and economic impacts of 
the concerned hazards. These estimates can be used to generate an evidence-based 
ranking of the impact of FBPs (i.e. risk ranking) and a baseline against which the 
effects of interventions can be evaluated (Devleesschauwer et  al. 2014a). Risk 
assessment further provides a scientific framework for evaluating the potential 
effects of intervention measures and, by combining with economic models, the 
expected efficiency of such measures.
In this chapter we review methods for quantifying disease burden, for quantify-
ing health risks and for ranking risks. We present applications to FBPs but acknowl-
edge that these methods can be applied to any hazard (i.e. any biological, chemical 
or physical agent able to cause harm or adverse effects). Burden assessment is even 
more general, as it can also be applied to outcomes (such as diarrhoea or epilepsy) 
and risk factors (such as unsafe water or lack of sanitation).
15.2  Quantifying Disease Burden
15.2.1  Health Impact
Quantifying health impact may be based on disease occurrence (prevalence or inci-
dence) or on the number of deaths (mortality). However, these simple measures of 
population health do not provide a complete picture of the impact of FBPs on human 
health (Batz et al. 2012; Devleesschauwer et al. 2015a). Indeed, while certain para-
sitic infections may be very common, their clinical impact may be limited. Infections 
with a highly prevalent parasite such as the pinworm, Enterobius vermicularis, for 
instance, have a very low burden because most of the cases are mild to asymptom-
atic and self-limiting (Knopp et al. 2012). Likewise, ignoring the age at which peo-
ple die and thus not considering how many years of healthy life might be lost due to 
death results in not fully capturing the impact of mortality. Disease severity, defined 
by the impact on quality of life and the duration of the concerned symptoms, and the 
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life expectancy at the age of death should thus be accounted for when quantifying 
burden of disease. Furthermore, simple measures of population health do not com-
bine the impacts of morbidity and mortality. This prohibits a comparative ranking of 
highly morbid but not necessarily fatal diseases, such as chorioretinitis due to con-
genital toxoplasmosis, and highly lethal diseases such as alveolar echinococcosis. 
The absence of a correct ranking complicates decisions on resource allocation 
priorities.
To overcome the limitations of simple measures such as incidence and mortality, 
summary measures of population health (SMPHs) have been developed as an addi-
tional source of information for measuring disease burden. The disability-adjusted 
life year (DALY) is currently the most widely used SMPH in public health research. 
Originally developed to quantify and compare the burden of diseases, injuries and 
risk factors within and across countries, the DALY summarises the occurrence and 
impact of morbidity and mortality in a single metric (Murray and Lopez 2013; 
Devleesschauwer et al. 2014b). The DALY is the key measure in the Global Burden 
of Disease (GBD) studies and is officially adopted by the World Health Organization 
for reporting on health information (Murray et al. 2012; WHO 2013).
The DALY is a health gap measure, measuring the healthy life years lost due to 
a disease or injury against some idealised health profile. DALYs are calculated by 
adding the number of years lived with disability adjusted for the severity of the 
disease (YLDs) and the number of years of life lost due to premature mortality 
(YLLs):
YLD = number of incident cases × duration until remission or death × disability 
weight
YLL = number of deaths × residual life expectancy at the age of death
An alternative formula for calculating YLDs was introduced by the GBD 2010 
study (Murray et al. 2012):
YLD = number of prevalent cases × disability weight
This formula reflects a prevalence perspective instead of an incidence perspec-
tive. The incidence perspective assigns all health outcomes, including those in 
future years, to the initial event (e.g. exposure to a certain FBP). This approach 
therefore reflects the future burden of disease resulting from current events. In the 
prevalence perspective, on the other hand, the health status of a population is 
assessed at a specific point in time, and prevalent diseases are attributed to initial 
events that happened in the past. This approach thus reflects the current burden of 
disease resulting from previous events. Although both perspectives are valid, the 
incidence perspective is more appropriate for FBPs, because it is more sensitive to 
current epidemiological trends, including the effects of intervention measures 
(Murray 1994; Devleesschauwer et al. 2015a).
Different approaches can be taken for calculating DALYs, depending on whether 
the interest lies in quantifying the burden of a health outcome, a hazard or a risk 
factor (Devleesschauwer et al. 2014c). A natural choice for quantifying the health 
impact of FBPs is the hazard-based approach. This approach defines the burden of 
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a specific FBP as that resulting from the health states, i.e. acute symptoms, chronic 
sequelae and death, that are causally related to the concerned parasite transmitted 
through food and which may become manifest at different time scales or have dif-
ferent severity levels (Mangen et  al. 2013). The starting point for quantifying 
DALYs is therefore typically the construction of a disease model or outcome tree, 
which is a schematic representation of the various health states associated with the 
concerned hazard, and the possible transitions between these states (Devleesschauwer 
et al. 2014c).
Table 15.1 shows selected causally related health states for ten important FBPs, 
highlighting the diverse nature of symptoms and sequelae linked to FBPs (Havelaar 
et al. 2012; Devleesschauwer et al. 2015a; Torgerson et al. 2015).
Disease burden can be calculated at different levels, ranging from the global to 
the individual level. Recently, the Foodborne Disease Burden Epidemiology 
Reference Group (FERG) of the World Health Organization quantified the global 
burden of foodborne disease (Havelaar et  al. 2015), including FBPs (Torgerson 
et al. 2015). Several authors have estimated the burden of FBPs at country level to 
support national decision-making (Polinder et al. 2012). Recently, Trevisan et al. 
(2017) estimated that in Tanzania, Taenia solium neurocysticercosis results in nearly 
20,000 new cases of epilepsy per year, leading to over 200 deaths and over 30,000 
DALYs. Some studies also include burden estimates at the individual level, i.e. the 
number of DALYs per case. Figure 15.1 contrasts the population and individual 
level burden of three FBPs in Nepal, highlighting the importance of congenital 
toxoplasmosis at both levels (Devleesschauwer et al. 2014d).
Table 15.1 Health states associated with foodborne parasites, based on Havelaar et al. (2012), 
Devleesschauwer et al. (2015a) and Torgerson et al. (2015)
Foodborne parasite Health state
Cryptosporidium spp. Diarrhoeal disease
Entamoeba spp. Diarrhoeal disease
Giardia spp. Diarrhoeal disease, postinfectious irritable bowel syndrome
Toxoplasma gondii Congenital toxoplasmosis: intracranial calcification, hydrocephalus, 
chorioretinitis, central nervous system abnormalities; acquired 
toxoplasmosis: acute fever-like illness, post-acute illness, 
chorioretinitis
Ascaris spp. Ascariasis infestation, abdominopelvic problems, wasting
Trichinella spp. Acute trichinellosis: diarrhoea, facial oedema, myalgia, fever, 
headache
Echinococcus granulosus Cystic echinococcosis: pulmonary, hepatic, central nervous system 
problems
Echinococcus 
multilocularis
Alveolar echinococcosis: abdominopelvic problems
Taenia solium Epilepsy, chronic headache, hydrocephalus
Foodborne trematodes Abdominopelvic, central nervous system, pulmonary problems
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15.2.2  Economic Impact
As for health impact, different approaches exist for estimating the economic impact 
of FBPs. The most commonly applied approach measures the cost of illness from a 
societal perspective, taking into account that FBPs have an impact on several stake-
holders in the society (Mangen et al. 2015). In cost-of-illness studies, a distinction 
is typically made between direct and indirect costs on the one hand and healthcare 
and non-healthcare cost on the other hands (Mangen et al. 2010). Direct healthcare 
costs are related to the resources provided by the healthcare sector, such as health-
care provider consultations, diagnosis, medication and hospitalisation. Direct non- 
healthcare costs are related to the resources used for healthcare that are not born by 
the healthcare system, such as over-the-counter medications and other patient 
copayments, and travel expenses to visit a healthcare provider. Indirect non- 
healthcare costs include productivity losses due to absenteeism or job loss of 
patients and their caregivers. Indirect healthcare costs, finally, are related to medical 
consumption in life years gained due to life-saving or death-postponing interven-
tions (van Baal et al. 2011) but are rarely included in cost-of-illness studies.
In Tanzania, the cost of illness of epilepsy due to Taenia solium neurocysticerco-
sis was estimated at over 5 million USD, with over 90% due to inactivity-related 
indirect costs (Trevisan et  al. 2017). In the Netherlands, the cost of illness of 
Cryptosporidium spp., Giardia spp. and Toxoplasma gondii was €8 million, €11 
Fig. 15.1 Population level (x axis) versus individual level (y axis) disease burden of three food-
borne parasites in Nepal (Adapted from Devleesschauwer et al. 2014d)
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million and €55 million, respectively, accounting for 16% of the economic impact 
of all considered foodborne pathogens (Mangen et al. 2015). Indirect non- healthcare 
costs were the most important component of Cryptosporidium spp. and Giardia spp. 
cost of illness, while direct healthcare costs were the dominant component of the 
cost of illness of T. gondii.
In addition to the costs linked to their health impact, FBPs may incur an eco-
nomic impact due to surveillance and other regulatory activities in place to monitor 
and prevent infection. In the EU, for instance, surveillance of pigs at slaughterhouse 
level for Trichinella spp. induces an estimated annual cost of €25 million (Torgerson 
2013), while the health impact of trichinellosis is negligible (Devleesschauwer et al. 
2015b). As many FBPs are zoonotic, livestock production losses due to clinical or 
subclinical infection further add to the economic burden. In Tanzania, the impact of 
lower prices for infected pigs was estimated at 2.8 million USD, accounting for 
35% of the total economic impact of T. solium in the country (Trevisan et al. 2017).
Although FBPs are of global concern, there are relatively few assessments of 
their global economic impact. Budke et al. (2006) estimated global monetary losses 
resulting from human and livestock cystic echinococcosis. Human-associated direct 
and indirect costs resulted in a global loss of 764 million USD, while livestock- 
associated losses due to liver condemnation and reductions in carcass weight, hide 
value, milk production and fecundity resulted in a global loss of 2 billion 
USD. Murrell (1991), Roberts et al. (1994) and Torgerson and Macpherson (2011) 
reviewed the economic impact of FBPs in selected countries.
15.3  Quantitative Microbiological Risk Assessment
Risk is defined by the Codex Alimentarius Commission as a function of the proba-
bility of an adverse effect consequential to a hazard in food and the severity of that 
effect (CAC 1999). Following this definition, integrative disease burden metrics 
such as DALYs and cost of illness are the most appropriate metrics for quantifying 
risk (Mangen et al. 2007). Nevertheless, risk is often expressed by simple metrics 
such as incidence of exposure or illness. Risk assessment is the scientific process 
that aims to examine this risk, in either a qualitative or quantitative way. Qualitative 
risk assessment results in nonnumerical risk estimates such as “negligible” or “high” 
risk or in semi-quantitative risk estimates (Ross and Sumner 2002; Newsome et al. 
2009). Such models are typically simple and quick to implement but include several 
subjective steps and do not allow for a full quantification of uncertainty and vari-
ability (WHO/FAO 2009). The remainder of this section will therefore focus on 
quantitative risk assessment. Quantitative microbiological risk assessment (QMRA) 
aims to quantify the human health effects resulting from exposure to microbiologi-
cal hazards including parasites, viruses, fungi, bacteria and their toxins. In contrast 
to chemical risk assessment, QMRA is a relatively young research field, with the 
emergence of applications to waterborne pathogens in the early 1990s (Rose et al. 
1991) and to foodborne pathogens in the mid-1990s (WHO/FAO 2009). Current 
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QMRA methods are able to consider the uncertainties and variability inherent to 
any available information and propagate these to the final risk estimate, thus provid-
ing an objective scientific basis for decision-making (Lammerding and Paoli 1997). 
As a result, QMRA methods are increasingly promoted at national and international 
level to safeguard public health and facilitate free trade (Schroeder et  al. 2007), 
especially in areas of water quality (Macler and Regli 1993) and food safety (Stella 
et al. 2013). Following the trend towards risk-based standards for foodborne patho-
gens, the Codex Committee on Food Hygiene explicitly calls for a risk-based 
approach in their guidelines for the control of Trichinella spp. and Taenia saginata 
in meat (FAO/WHO 2014).
QMRA fits into a larger process of risk analysis (Fig. 15.2), which is further 
characterised by risk management (i.e. the identification, selection and implementa-
tion of control policies) and risk communication (i.e. the mutual interaction between 
scientists, risk managers and the general public). QMRA itself is classically divided 
in four components (Fig. 15.2; Buchanan 1998; CAC 1999; Lammerding and Fazil 
2000; Buchanan et al. 2000). Hazard identification is the process of identifying the 
biological hazards capable of causing adverse health effects following exposure, as 
well as the nature of these adverse health effects. Exposure assessment is the evalu-
ation of the likely intake of the biological agent via relevant exposure routes. Dose- 
response assessment (the quantitative form of hazard characterisation) is the 
evaluation of the functional relationship between the ingested dose and the proba-
bility of an adverse response, such as infection, illness or death. Risk characterisa-
tion, finally, is the estimation of the probability of occurrence and severity of the 
Fig. 15.2 Risk analysis framework for microbiological hazards
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potential adverse health effects in a population, based on the results of the preceding 
three components.
15.3.1  Hazard Identification
Hazard identification is the first step in a formal risk assessment and aims to identify 
which hazards are present in the food and which adverse health effects they are able 
to cause. This activity is therefore mainly a qualitative review of available informa-
tion. The main focus of hazard identification is typically to determine which health 
states are causally related to the concerned hazards, thus corresponding to the dis-
ease models used in disease burden quantifications. This assessment is less involved 
for FBPs than, for example, chemicals, as the cause-and-effect relationship can 
typically be observed in individual cases, allowing for categorical attribution. For 
instance, a case of diarrhoea can be attributed to Giardia spp. if a high number of 
cysts are observed in the stool, or a case of epilepsy can be attributed to Taenia 
solium neurocysticercosis if cysticerci are witnessed in the brain.
However, when the FBP elevates the risk of a disease that occurs in the popula-
tion from other causes as well, attribution can only be made at a population level 
and not on an individual basis. This is the case for certain chronic sequelae that may 
be linked to FBPs, such as irritable bowel syndrome, Giardia spp., schizophrenia 
and Toxoplasma gondii. As a result, there is considerably more uncertainty and 
debate, surrounding these causal relationships. When categorical attribution is not 
feasible, a valid approach for quantifying the association between exposure and 
outcome is to use a counterfactual analysis in which the current disease outcomes 
with current exposure are compared to the disease outcomes under an alternate 
exposure scenario (e.g. a minimum risk exposure which could be zero or some 
accepted background level; Prüss-Üstün et al. 2003). This allows for the calculation 
of a population attributable fraction or population attributable risk, which is a mea-
sure of the association between exposure and outcome at the population level. 
Estimates of the population attributable fraction for Toxoplasma gondii-associated 
schizophrenia, for instance, ranged between 9% (Torgerson et al. 2015) and 21% 
(Smith 2014).
15.3.2  Exposure Assessment
Exposure assessment aims to evaluate the expected dose, d, of the ingested hazard 
(WHO/FAO 2008). Under the assumption of independence, this dose can be 
obtained as the product of the concentration of the hazard in the ingested medium 
(e.g. meat, water, aerosol, etc.), μ, and the amount of medium consumed, m. 
Typically, the concentration μ of the hazard in the medium is not exactly known but 
must be estimated from random samples from the medium of interest, in which the 
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concentration, count or the presence/absence of the hazard is measured. By fitting 
parametric models to these external data sources, the concentration in the medium, 
μ, can be estimated (Haas et al. 2014). Unless the point of consumption is the only 
interest, exposure assessment should also describe the relevant exposure pathways 
along the farm-to-fork chain and the different processes that affect the probability 
and level of exposure of the consumed end product (WHO/FAO 2008).
15.3.2.1  Exposure Assessment from Concentration Data
Different parametric models may be appropriate to describe the concentration μ of 
a FBP.  In general, any non-negative continuous probability distribution function 
may be a possible model. In literature, the most commonly applied distribution has 
been the log-normal model. Alternative models are the gamma, Weibull, inverse 
Gaussian (aka Wald) and generalised inverse Gaussian model (Haas et al. 2014).
Depending on the analytical sensitivity of the test, assays may exhibit a certain 
detection limit or lowest measurable concentration. Samples for which the true con-
centration is below this detection limit are called below-detection-limit samples. 
Such samples are an example of left-censored data and require adapted statistical 
approaches (Haas et al. 2014).
15.3.2.2  Exposure Assessment from Count Data
Count assays provide the most informative data for estimating hazard concentra-
tions, reporting both the number of organisms detected in the sample and the sample 
quantity (e.g. volume, weight, surface area, etc.), which may differ across samples. 
Haas and Rose (1996), for instance, presented Cryptosporidium oocyst counts from 
a water supply in the United States. Samples were collected once a week over a one- 
year study period, with sample volumes ranging from 18 to 227 litres. Surveillance 
of Trichinella spp. in pigs may be done by artificial digestion of a pooled sample of 
1 g diaphragm pillar meat from each of 100 pigs, quantifying exposure as the num-
ber of larvae in a sample of 100 g (Commission Regulation (EC) No 2075/2005).
The most basic assumption to model μ from count data is that the distribution of 
hazards in the sample follows a Poisson distribution with mean μV, implying that 
the hazard is distributed randomly in the medium. Under the Poisson model, the 
probability that a sample of quantity V contains k organisms is given by:
 
P x k
V
k
VP
k
=( ) = ( ) −( )
µ
µ
!
exp
 
Alternative models relax the Poisson assumption of randomness and account for 
extra-Poisson variability. Such models are discrete mixture distributions PM(x) of 
the general form:
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in which PP(x = k) is a Poisson model and h(μ) is a non-negative continuous prob-
ability density function describing the variability in μ, as described above. Assuming 
a gamma model for the mean concentration μ leads to a negative binomial model for 
the counts, while the other models presented above would lead to a Poisson log- 
normal, Poisson-Weibull, Poisson-inverse Gaussian and Poisson-generalised 
inverse Gaussian model, respectively (Haas et al. 2014; Jongenburger et al. 2012). 
Except for the Poisson log-normal and Poisson-Weibull model, analytical solutions 
exist for these hierarchical mixture models (Haas et al. 2014). Bayesian methods 
allow modelling these hierarchies explicitly, hereby avoiding the need for an ana-
lytical solution.
15.3.2.3  Exposure Assessment from the Presence/Absence Data
Dilution or titration assays report the presence or absence of the hazard in a certain 
quantity of the concerned medium. Letting y denote the presence/absence of the 
hazard, the probability of observing the hazard in the sample can be modelled as a 
Bernoulli process:
 
P y y
y( ) = −( ) −pi pi1 1  
where π is the probability that the sample contains one or more organisms, P(k ≥ 0) 
= 1 − P(k = 0). Again, if we assume a Poisson model to describe the occurrence of 
organisms in the sample, this yields P(k = 0) = exp(−μV). The probability of observ-
ing the hazard in the sample is therefore given by the following Bernoulli-Poisson 
mixture model:
 
P y V V
y y( ) = − −( )( ) −( )( ) −1 1exp expµ µ
 
15.3.2.4  Farm-to-Fork Pathway Models
Exposure assessment often requires a description of the pathway from production to 
consumption. Indeed, microbiological hazards can enter foods at many points in the 
chain, and their prevalence and concentration may change along the chain. The 
transmission of pathogens along a farm-to-fork pathway may be modelled using 
mathematical models in which the output of the previous step is the input of the next 
step. To formalise this idea, Nauta (2008) introduced the modular process risk 
model (MPRM), which models the food pathway as a sequence of well-defined 
modules. Each module corresponds to one-process step, which in term is defined by 
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one or more basic processes. These basic processes can be product handling pro-
cesses, such as mixing, partitioning, removal and cross-contamination, or microbio-
logical processes, such as growth and inactivation. To support the modelling of 
microbiological processes, an online database of microbial growth and survival 
curves, ComBase, has been developed (Baranyi and Tamplin 2004).
In a QMRA model for Toxoplasma gondii in the Netherlands, Opsteegh et al. 
(2011) used bradyzoite concentration and portion size data to estimate the bradyzo-
ite number in infected unprocessed portions for human consumption. To estimate 
the number of bradyzoites per processed portion, they applied reduction factors for 
salting, freezing and heating (i.e. corresponding to the microbiological process of 
inactivation). Guo et al. (2015) estimated the exposure risk to T. gondii from various 
meat products consumed in the United States based on a qualitative farm-to-retail 
pathway model. The included modules were farm, abattoir, storage and transporta-
tion, meat processing, packaging and retail, with two product handling processes, 
i.e. removal and cross-contamination, considered in the different modules.
15.3.3  Dose-Response Assessment
The dose-response assessment, also referred to as the quantitative component of 
hazard characterisation, aims to describe the relationship between the ingested dose 
of the hazard and the extent of the associated adverse health effects (Buchanan et al. 
2000). The dose-response relationship for microbiological hazards shows some 
essential differences with that of chemical hazards.
First, a clear distinction needs to be made between infection and illness. In 
QMRA, infection is defined as the invasion (and multiplication) of the microbio-
logical hazard in the host and the reaction of the host to these events. Infection may 
be ascertained by the detection of the hazard in the host’s tissues, secreta or excreta 
or by detecting antibodies against the hazard. Infection does not necessarily lead to 
disease and may remain asymptomatic. Whether or not illness develops depends on 
the balance between the hazard’s virulence and infectivity and the host’s suscepti-
bility. In severe cases, illness will be followed by death. Unlike for chemical haz-
ards, it is postulated that even one microbiological organism is sufficient to cause 
illness, even though the likelihood of illness increases with increasing numbers of 
ingested hazards (Teunis and Havelaar 2000).
A second important distinct feature of the dose-response assessment step for 
microbiological hazards is the type of data typically used to establish dose-response 
curves, i.e. human feeding trials or outbreak data (Mena 2006). Extrapolation of 
animal studies for determining dose-response is less commonly applied, in contrast 
to chemical risk assessment. In feeding trials, participants are given a range of doses 
(through ingestion, inhalation or direct contact), and a human health endpoint of 
interest (infection and/or illness) is determined. Typically, due to ethical constraints, 
healthy adults are used, and a relatively high amount of (low virulent) dose is 
administered to be able to use as few participants as possible but still observe the 
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adverse event. However, in typical contamination situations, people will be exposed 
to lower doses of (more virulent) hazards. An important issue in dose-response 
modelling is therefore the prediction of the probability of the adverse health effect 
in low-dose ranges (Havelaar and Swart 2014).
A third distinct feature is that microbiological organisms are distinct or discrete 
particles, which is accounted for when constructing dose-response models. Finally, 
unlike chemical hazards, repeated exposures may induce acquired immunity, 
thereby reducing the risk of infection and/or illness (Havelaar and Swart 2014).
15.3.3.1  Dose-Infection Models
Different models have been proposed to model the relationship between exposure 
and infection. It is common in QMRA literature to distinguish between mechanistic 
models, which have a biological basis, and empirical models, for which no biologi-
cal basis is apparent (Buchanan et al. 2000).
Currently, the exponential and Beta-Poisson models, both introduced by Haas 
(1983), are recommended for foodborne and waterborne hazards (Schroeder et al. 
2007). Both models are mechanistic models, derived from a biological reasoning 
underlying the relationship between dose and infection. This biological process is 
assumed to consist of distinct sequential steps. First, a host must ingest one or more 
viable hazard. Then, some of these ingested hazards must survive the host defences 
and multiply to cause infection. Further assumptions can be made about the mini-
mum number of surviving organisms kmin needed to initiate infection. Models in 
which kmin = 1 are called single-hit models. Empirical evidence shows that, under 
certain circumstances, single hazards are indeed able to cause infection; a single 
viable egg of Echinococcus can, for instance, cause infection and disease (Gemmell 
1990). Hence, the common consensus is to derive mechanistic dose-infection mod-
els that are single-hit models. However, for nematodes such as Trichinella spp., 
there must be at least one male and one female survivor to initiate infection, requir-
ing adapted modelling approaches (Teunis et al. 2012).
The exponential dose-response model assumes that the ingested doses among 
exposed hosts are Poisson distributed and that each ingested hazard is associated 
with an equal, independent probability of initiating a response:
 
Pr exp ,infection|dose( ) = − −( ) >1 0rd r  
where d is the ingested dose and r is a rate parameter equal to the probability of a 
single organism initiating a response.
Messner and Berger (2016) extended the basic exponential dose-response model 
with a parameter π reflecting the susceptible fraction of human hosts, leading to an 
exponential with immunity model:
 
Pr exp , ,infection|dose( ) = − −( )( ) > < <pi pi1 0 0 1rd r
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When r is assumed to equal 1, i.e. each hazard is capable of initiating infection, 
this model reduces to a fractional Poisson model, which is also the probability of 
exposure given an average dose d:
 
Pr exp ,infection|dose( ) = − −( )( ) < <pi pi1 0 1d
 
In the Beta-Poisson model, ingested doses are assumed to be Poisson distributed 
as well, but now the probability that an individual organism initiates a response is 
assumed to follow a Beta distribution. As a result, the Beta-Poisson model allows to 
characterise variability of the host-pathogen survival probability. The exact Beta- 
Poisson model is given by:
 
Pr , ,infection|dose ,, ,,( ) = − + −( ) > >1 0 01 1F dα α β α β  
where 1F1 denotes the Kummer confluent hypergeometric function and α and β are 
the parameters of the Beta distribution. Furumoto and Mickey (1967) proposed an 
approximation to the confluent hypergeometric function, resulting in the more com-
monly used approximate Beta-Poisson model:
 
Pr / , ,infection|dose( ) = − +( ) − > >1 1 0 0d β α α β  
For many datasets where β ≫ 1 and α ≪ β, the differences between the approxi-
mation errors provided by applying the approximate Beta-Poisson as compared to 
those of the hypergeometric function are negligible. However, Teunis and Havelaar 
(2000) showed that this approximation is in fact not a single-hit model and that it 
becomes problematic at low doses when the assumptions postulated by Furumoto 
and Mickey (1967) are not met. Furthermore, even when the most likely values of α 
and β do satisfy the conditions, the assumptions may not be met for every individual 
pair of parameter samples in the uncertainty set. Therefore, they promote the use the 
exact Beta-Poisson model.
In addition to the mechanistic models, various so-called empirical models are 
used to describe the relationship between ingested dose and expected response 
(Buchanan et al. 2000). These models do not arise from biological reasoning but 
follow the logic that the probability of a response should be zero at dose zero, reach 
one when dose becomes very high and increase monotonically in between. These are 
properties of sigmoidal functions, including cumulative distribution functions. Some 
of the empirical models described in literature are the log logistic, log probit, extreme 
value, Weibull and gamma-Weibull model (Haas et al. 2014; Holcomb et al. 1999).
15.3.3.2  Dose-Illness Models
In contrast to dose-infection models, less work has been performed on models 
describing the relationship between dose and onset of illness. Historically, research-
ers have assumed that the probability of illness following infection is independent 
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of the dose (Rose et al. 1991; Haas et al. 1993; Haas and Rose 1996). Under this 
assumption, the probability of illness given dose can be factorised as follows:
 
Pr Pr Prillness|dose illness|infection infection|dose( ) = ( ) ( )  
Pouillot et al. (2004), for instance, modelled the probability of illness following 
Cryptosporidium spp. infection in the immunocompetent as a Beta (9,11) distribu-
tion, which has a mean of 45%. For the immunocompromised, they assumed a prob-
ability of illness of 100%.
In general, however, the dose-illness relationship is given by Namata et  al. 
(2008):
 
Pr Pr Prillness|dose illness|,infection|,dose infection|d( ) = ( ) ose( )  
According to Teunis et al. (1999), the probability of illness given infection and 
dose can in theory follow any of three distinct shapes, i.e. increasing, decreasing or 
constant. When the probability of illness is increasing, the resulting dose-illness 
relationship has a similar shape as the dose-infection models, so that these models 
can be applied to model dose-illness. A general empirical framework for modelling 
all possible dose-illness relationships has been proposed by Namata et al. (2008) 
and Bollaerts et al. (2008), who used fractional polynomials and generalised linear 
mixed models to model dose-illness relationships for Campylobacter and 
Salmonella. So far little work has been done on mechanistic dose-illness models, 
especially not for FBPs. Buchanan et al. (2000) presented a mechanistic dose- illness 
model composed of three compartments, i.e. gastric acidity barrier, attachment/
infectivity and morbidity/mortality. Havelaar and Swart (2014) discussed dose- 
illness models that can incorporate both the effects of dose-dependency and acquired 
immunity in the probability of illness given infection.
15.3.3.3  Dose-Response Models for Foodborne Parasites
Table 15.2 provides an overview of proposed dose-response models for FBPs. To 
date, most dose-response assessments of FBPs have focused on intestinal protozoa, 
particularly Cryptosporidium spp., and were typically performed in the context of 
waterborne transmission. Recently, dose-response models have been introduced for 
Toxoplasma gondii and for macroparasites such as Ascaris lumbricoides and 
Trichinella spp.
Information on Cryptosporidium spp. dose-response first became available from 
three feeding studies in healthy human volunteers initiated in 1993 at the University 
of Texas (DuPont et al.1995) ; Chappell et al. 1999); Okhuysen et al. 1999). These 
studies used three distinct Cryptosporidium parvum isolates, referred to as the Iowa, 
TAMU and UCP strains. Messner et  al. (2001) fitted exponential dose-response 
models to these datasets and performed a random effect meta-analysis of the three 
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Table 15.2 Estimated dose-response models for foodborn parasites
Foodbome parasite Response Model Reference
Cryptosporidium parvum, 
Iowa strain
Oocyst 
detection
Exponential ( rˆ  = 0.00419)  Teunis et al. 
(1999)
Cryptosporidium parvum, 
Iowa strain
Clinical 
definition of 
infection
Exponential ( rˆ  = 0.00526) Messner et al. 
(2001) and 
Teunis et al. 
(2002a)
Cryptosporidium parvum, 
Iowa strain
Clinical 
definition of 
infection
Hypergeometric ( αˆ  = 0.801, 
βˆ  = 56.24)
Teunis et al. 
(2002a)
Cryptosporidium parvum, 
Iowa strain; 
immunocompromised mice
Oocyst 
detection
Exponential ( rˆ  = 0.354) Pouillot et al. 
(2004)
Cryptosporidium parvum, 
TAMU strain
Clinical 
definition of 
infection
Exponential ( rˆ  = 0.0573) Messner et al. 
(2001) and 
Teunis et al. 
(2002a)
Cryptosporidium parvum, 
TAMU strain
Clinical 
definition of 
infection
Hypergeometric ( αˆ  = 1.831, 
βˆ  = 18.06)
Teunis et al. 
(2002a)
Cryptosporidium parvum, 
UCP strain
Clinical 
definition of 
infection
Hypergeometric 
( αˆ  = 1.17e−5, βˆ  = 8.15e−6)
Teunis et al. 
(2002a)
Cryptosporidium spp., pool 
of seven datasets
Clinical 
definition of 
infection
Exponential with immunity 
( ≠ˆ  = 0.737, rˆ  = 0.608)
Messner and 
Berger (2016)
Cryptosporidium spp., pool 
of seven datasets
Clinical 
definition of 
infection
Fractional Poisson 
( ≠ˆ  = 0.737)
Messner and 
Berger (2016)
Cryptosporidium spp., pool 
of seven datasets
Clinical 
definition of 
infection
Beta-Poisson ( αˆ  = 0.116, 
βˆ  = 0.121)
Messner and 
Berger (2016)
Giardia spp. Cyst 
excretion
Exponential ( rˆ  = 0.0198) Rose et al. 
(1991)
Toxoplasma gondii, type II; 
mice
Bioassay 
positive
Exponential ( rˆ  = 0.001535) Dubey (1997), 
Derouin et al. 
(2005), 
Opsteegh et al. 
(2011), and 
Guo et al. 
(2015)
Toxoplasma gondii, type II; 
mice, with scaling factor
Bioassay 
positive
Exponential 
( rˆ  = 0.001535 × 0.005)
Guo et al. 
(2015)
Toxoplasma gondii, type II; 
mice
Bioassay 
positive
Beta-Poisson ( αˆ  = 1.479, 
βˆ  = 582.4)
Guo et al. 
(2015)
(continued)
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datasets, highlighting the important heterogeneity between the three involved 
strains. Teunis et al. (2002a) fitted exponential and hypergeometric dose-response 
models to the individual and pooled datasets and developed a two-level dose- 
response model to simultaneously model the heterogeneity between and within iso-
lates. By including the IgG level as a covariate in the single-hit model, they further 
explored the effect of immunity on the relationship between dose and infection or 
acute illness (Teunis et al. 2002b). Recently, Messner and Berger (2016) compiled 
seven human challenge dose-response studies for Cryptosporidium spp., including 
five studies using C. parvum and one each using Cryptosporidium hominis and 
Cryptosporidium muris. The best fitting models indicated that human susceptibility 
may be a more important source of heterogeneity than virulence differences. 
Pouillot et al. (2004), finally, proposed an exponential dose-response model for the 
immunocompromised, based on a feeding study in immunocompromised mice.
The only Giardia spp. dose-response model available in literature is given by 
Rose et al. (1991). They fitted an Exponential dose-response model to data from 
human feeding studies published in the 1950s. As noted by Teunis et al. (1999), 
these results indicated a high single-hit probability of infection but, as none of the 
infected persons developed gastroenteritis, did not provide any information on the 
probability of illness.
In a QMRA for meat-borne Toxoplasma gondii infection in the Netherlands, 
Opsteegh et  al. (2011) used an exponential dose-response model established for 
T. gondii type II in mouse experiments (Dubey 1997); Derouin et al. 2005). Guo 
et al. (2015) found that this dataset was reasonably well explained by the exponen-
tial dose-response model and less so by the Beta-Poisson dose-response model. 
They also computed scaling factors so that these mouse-derived models could pre-
dict T. gondii infection in humans.
Schönning et al. (2007) and Machdar et al. (2013) modelled the dose-response 
relationship of Ascaris lumbricoides as an exponential model with r = 1, corre-
sponding to the maximum risk curve (Teunis and Havelaar 2000). Navarro et al. 
(2009) estimated a Beta-Poisson dose-response model for A. lumbricoides, by com-
bining A. lumbricoides infection rates from the Mezquital Valley in Mexico with 
data on Ascaris egg concentrations in crops and soil.
Table 15.2 (continued)
Foodbome parasite Response Model Reference
Toxoplasma gondii, type II; 
mice, with scaling factor
Bioassay 
positive
Beta-Poisson ( αˆ  = 1.479, 
βˆ  = 582.4/0.003)
Guo et al. 
(2015)
Ascaris lumbricoides; 
exposure through crops
Egg 
excretion
Beta-Poisson ( αˆ  = 0.104, 
βˆ  = 1.096)
Navarro et al. 
(2009)
Ascaris lumbricoides; 
exposure through soil
Egg 
excretion
Beta-Poisson ( αˆ  = 0.104, 
βˆ  = 0.044)
Navarro et al. 
(2009)
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Takumi et al. (2009) and Teunis et al. (2012) analysed nine published outbreaks 
of human trichinellosis to determine the dose-response of Trichinella spp. in 
humans, using seroconversion as response outcome. They extended the Beta-
Poisson dose- response model by allowing for extra-Poisson variation in the ingested 
dose and by taking into account that both male and female worms need to be 
ingested to initiate infection. Their model resulted in a single-hit infection probabil-
ity of around 1%.
15.3.4  Risk Characterisation
Risk characterisation is the final stage of QMRA and generates an estimate of the 
likelihood and extent of the adverse health effects a population will experience due 
to concerned hazard. This is achieved by integrating exposure and dose-response 
assessments, where the outcomes of the former analysis serve as an input to the lat-
ter analysis (Buchanan et al. 2000).
A crucial aspect of risk characterisation is the proper reflection of the level of 
confidence in the final risk estimates. In this context, the identification and quantifi-
cation of uncertainty and variability play an important role, as well as a clear articu-
lation of all assumptions and their support. Uncertainty relates to a lack of knowledge 
about the system (i.e. model uncertainty) or the parameters characterising the sys-
tem (i.e. parameter uncertainty). Uncertainty can be mitigated by gaining knowl-
edge, e.g. by collecting information on a larger sample size. Variability on the other 
hand relates to the stochastic nature of the system and cannot be reduced by increas-
ing the sample size.
In earlier years, uncertainty was explored through scenario or one-way sensitiv-
ity analyses, generating, for instance, an average, conservative and worst-case risk 
estimate (Jaykus 1996). Improvements in computational power have now resulted 
in Monte Carlo or Latin hypercube simulation methods becoming the standard 
approach for propagating parameter uncertainty. In brief, these methods simulate 
random draws from probability distributions reflecting the uncertainty in the input 
parameters and use these random draws to establish a distribution of plausible risk 
estimates. Two-dimensional Monte Carlo methods may furthermore be used to 
additionally, but separately, capture the effects of variability (Miconnet et al. 2005; 
Pouillot and Delignette-Muller 2010).
Recently, Bayesian methods are increasingly used in QMRA to propagate param-
eter uncertainty (Delignette-Muller et al. 2006; Smid et al. 2010; Williams et al. 
2011). With increasing computational power, Bayesian models may now be 
 developed to capture the often complex processes leading to human exposure 
(Greiner et al. 2013; Schmidt et al. 2013).
A variety of software tools are being applied in the context of QMRA, some of 
which specifically developed for the purpose of risk assessment. To date, the most 
comprehensive tool for QMRA is FDA-iRisk, a web-based quantitative risk 
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 assessment system to estimate and compare the risk of foodborne illness from 
microbial and chemical hazards (Chen et al. 2013). iRisk integrates seven model 
elements, i.e. definition of foods, hazards and population groups; process models 
(cf. MPRM); consumption models; dose-response models; and health outcomes 
(with default DALY per case values for selected hazards). The different model 
inputs are integrated through Monte Carlo simulations to quantify variability in the 
resulting risk estimates.
Other QMRA tools are dedicated to risk characterisation, exposure assessment 
or dose-response assessment. Risk characterisation is often performed in Excel with 
the add-on @RISK, which provides random number generators for a variety of 
probability distributions and functionalities for sensitivity analysis and plotting. 
Other add-ons, such as PopTools, Ersatz and Crystal Ball, provide similar fea-
tures. Analytica is a visual software environment for the quantitative analysis of 
influence diagrams, which may also be applied in the context of QMRA.  Other 
analysts developed models in general scientific software environments such as R, 
SAS and MATLAB (WHO/FAO 2008). Several R packages provide specific 
QMRA functions, e.g. mc2d, which is dedicated to two-dimensional Monte Carlo 
(Pouillot and Delignette-Muller 2010) and fitdistrplus, which allows fitting uni-
variate models to (possibly censored) data.
15.4  Risk Ranking
In a time of increasing (recognised) threats and decreasing financial resources, there 
is a growing need to rationally allocate available means. Consequently, risk ranking 
is increasingly used within the food safety risk analysis framework (Stella et  al. 
2013). The aim of these exercises is to prioritise for decision-making certain haz-
ards, hazard-commodity pairs or exposure routes for a given hazard, based on their 
perceived importance. As different stakeholders have their own prioritisation objec-
tives and beliefs, the outcome of such exercises is necessarily context dependent. 
Consequently, there is no unique or intrinsically correct ranking of risks.
The main purpose of burden and risk assessments is often to rank different haz-
ards according to the health or economic impact. Figure 15.3 shows the FERG rank-
ing of FBPs according to their global health impact, quantified in terms of DALYs 
(Torgerson et al. 2015).
Using a single criterion to rank risks may however be insufficient as diseases 
vary greatly in incidence, clinical manifestations, control measures, transmission 
potential and socio-economic impact in animals and humans. Trichinella spp., for 
instance, have a near negligible health impact in Europe, while their economic 
impact remains important due to continuous monitoring and trade implications 
(Devleesschauwer et al. 2015b). It may therefore be required to base the ranking of 
risks on multiple criteria (Mangen et al. 2010). To quantify the disease burden of 
various foodborne hazards in the Netherlands in 2011, Mangen et  al. (2015) 
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 calculated DALYs and cost-of-illness estimates, both at the population and indi-
vidual level. The different criteria led to different rankings, with some hazards scor-
ing high on multiple criteria.
Ideally, however, a risk ranking exercise should result in a single ranking taking 
into account multiple criteria. Some authors combined DALYs and economic 
impact estimates by assuming one DALY to correspond to an economic loss equal 
to the per capita gross national product (Torgerson et  al.(2008). This approach 
belongs to the family of multi-criteria decision analysis (MCDA) methods. In 
MCDA, an overall importance measure is constructed based on different criteria, 
which are assigned weights reflecting their perceived contribution (Cardoen et al. 
2009; Havelaar et  al. 2010; FAO/WHO 2014; Robertson et  al. 2015). As these 
weights imply a normative choice, the definition of weights should reflect social 
preferences or expert opinion. The selection of criteria to be scored typically 
depends on expert opinion. The (quantitative, semi-quantitative or qualitative) scor-
ing of the criteria can be based on existing data or on expert elicitation. Despite its 
subjective perfume, MCDA provides a transparent and consistent framework for 
ranking risks (Anderson et al. 2011). It also allows including criteria for which no 
quantifications are available or possible. In the joint Food and Agriculture 
Organization of the United Nations and World Health Organization multi-criteria- 
based ranking of FBPs, trade relevance and impacts on economically vulnerable 
communities were included, in addition to criteria related to health impact. 
Figure  15.4 shows the outcome of this exercise, confirming the importance of 
Taenia solium at a global level.
Fig. 15.3 Disability-adjusted life year-based global ranking of foodborne parasites according to 
Torgerson et al. (2015)
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